article thumbnail

HIMSS23: Epic analytics leader details efforts to bring GPT-4 into healthcare and growing work in genomics, life sciences

Fierce Healthcare

HIMSS23: Epic analytics leader details efforts to bring GPT-4 into healthcare and growing work in genomics, life sciences hlandi Thu, 04/20/2023 - 08:09

article thumbnail

AWS launches new genomics data service for life sciences, healthcare companies

Fierce Healthcare

AWS launches new genomics data service for life sciences, healthcare companies. Wed, 11/30/2022 - 14:21.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Viome Life Sciences unveils at-home oral, throat cancer detection test

Fierce Healthcare

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers. | The test relies on Viome’s proprietary RNA sequencing technology and AI to measure gene expression of the oral microbiome and human cells in each patient’s saliva, which are used to identify early biomarkers associated with oral and throat (..)

article thumbnail

Microsoft life sciences leader on what makes for successful disruptors

Healthcare It News

Even in regions where healthcare delivery mechanisms are abundant, demand can be overwhelming while other healthcare operational challenges interfere with patient outcomes. The company's zero trust platform encrypts protected data at rest, in transit and as it is processed by algorithms to accelerate AI adoption in healthcare.

article thumbnail

The paperless future of healthcare and life sciences

Healthcare It News

Sponsor: DocuSign Primary topic: Privacy & Security Topic: Cloud Computing Patient Engagement Privacy & Security Resource Central: White Papers External url: [link] Thumbnail: Body: Enterprise Taxonomy: Short Headline: The paperless future of healthcare and life sciences Region Tag: Global Edition Node settings: Exclude from Accelerate RSS (..)

article thumbnail

Viome Life Sciences banks $86.5M round, partners with CVS to sell at-home diagnostic tests

Fierce Healthcare

At-home diagnostics startup Viome Life Sciences snagged $86.5 At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores. |

article thumbnail

IPO vs. Acquisition for Life Science Companies: Expert Q&A

HIT Consultant

Taylor Wirth, Partner at Barnes & Thornburg Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. How can life science companies assess the market receptiveness to their potential IPO, especially considering the biotech/pharma sector?